Literature DB >> 1185235

Experimental mitochondrial myopathy produced by in vivo uncoupling of oxidative phosphorylation.

C Melmed, G Karpati, S Carpenter.   

Abstract

Two uncouplers of mitochondrial oxidative phosphorylation [2,4-dinitrophenol (DNP) and carbonylcyanide-m-chlorophenylhydrazone (CCCH)] were infused intra-arterially into a branch of the lower abdominal aorta of anesthetized rats over a 60-180 min period. An acute, severe, hypermetabolic state with systemic lactic acidosis and stiffness of the lower extremeities developed. In the plantaris muscles, by histochemistry, numerous "ragged red" fibers were present after the infusion. The "ragged red" areas presumably represented an absolute increase in mitochondrial mass in affected muscle fibers. By electron microscopy, linear inclusions were present in the intracristal space of many mitochondria. Simultaneous infusion of DNP and chloramphenicol, an inhibitor of mitochondrial protein synthesis, prevented the formation of ragged red fibers but not the intracristal inclusions. Infusion of relatively large amounts of oleic acid produced histochemical and electron-microscopic changes similar to those caused by the uncouplers. A possible pathogenesis of these reversible mitochondrial changes was discussed and their potential relevance to morphologic abnormalities of skeletal muscle mitochondria in human diseases was reviewed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185235     DOI: 10.1016/0022-510x(75)90204-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

1.  On the pathogenesis of mitochondrial myopathies. An experimental study.

Authors:  V Sahgal; V Subramani; R Hughes; A Shah; H Singh
Journal:  Acta Neuropathol       Date:  1979-05-15       Impact factor: 17.088

Review 2.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

3.  Ultrastructural study of the childhood mitochondrial myopathic syndrome associated with lactic acidosis.

Authors:  Y Kobayashi; S Miyabayashi; G Takada; K Narisawa; K Tada; T Y Yamamoto
Journal:  Eur J Pediatr       Date:  1982-09       Impact factor: 3.183

4.  Ophthalmoplegia-plus.

Authors:  L A Bastiaensen; H H Jaspar; A M Stadhouders
Journal:  Doc Ophthalmol       Date:  1979-03-15       Impact factor: 2.379

5.  Mitochondrial abnormalities of late motor neuron degeneration following poliomyelitis and other neurogenic muscular atrophies.

Authors:  D Schiffer; L Palmucci; A Bertolotto; G Monga
Journal:  J Neurol       Date:  1979-09       Impact factor: 4.849

Review 6.  Creatine metabolism and the consequences of creatine depletion in muscle.

Authors:  M Wyss; T Wallimann
Journal:  Mol Cell Biochem       Date:  1994 Apr-May       Impact factor: 3.396

7.  Experimental germanium myopathy.

Authors:  I Higuchi; K Takahashi; K Nakahara; S Izumo; M Nakagawa; M Osame
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Immunohistochemical and biochemical indicators of muscle damage in vitro: the stability of control muscle and the effects of dinitrophenol and calcium ionophore.

Authors:  T R Helliwell; M J Jackson; J Phoenix; P MacLennan; J West-Jordan; R H Edwards
Journal:  Int J Exp Pathol       Date:  1994-10       Impact factor: 1.925

9.  Direct real-time quantification of mitochondrial oxidative phosphorylation efficiency in permeabilized skeletal muscle myofibers.

Authors:  Daniel S Lark; Maria J Torres; Chien-Te Lin; Terence E Ryan; Ethan J Anderson; P Darrell Neufer
Journal:  Am J Physiol Cell Physiol       Date:  2016-06-22       Impact factor: 4.249

10.  Experimentally induced defects of mitochondrial metabolism in rat skeletal muscle. Biological effects of the mitochondrial uncoupling agent 2,4-dinitrophenol.

Authors:  E Byrne; D J Hayes; E A Shoubridge; J A Morgan-Hughes; J B Clark
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.